HCPLive | The American Journal of Managed Care | Pharmacy Times | OTCGuide.net | Politics | ONCLive | Medgadget | EchoJournal
KevinMD | Medical Smartphones | Medicine and Technology | Mobile Health Computing | Non-Clinical Medical Jobs, Careers, and Opportunities

You may type link codes into the search box above.
Register   |   Login
 
 
   ecco
 
Conference 360
 
   
This year's meeting will feature presentations on late-breaking oncology research.
   

Day 5:

Studies Demonstrate Effectiveness of Exemestane in Early Stage Breast Cancer

Can HPV Vaccination Eradicate Cervical Cancer?

Targeting Soft-Tissue Sarcoma with Heat During Chemotherapy Improves Outcomes

On the Road to Personalizing Radiation Therapy

Researchers Propose Standard of Care for Patients with Partially Platinum-Sensitive Ovarian Cancer





Day 4:

PRIME Trial Offers More Good News for Panitumumab in Metastatic Colorectal Cancer

Progression-free Survival Significantly Improved in Breast Cancer Patients on Sorafenib

Novel TAK-1 Inhibitor Reduces Resistance of Pancreatic Cancer Cells to Chemotherapy

Questioning Cancer Research Priorities

ABCSG-24 Finds Neoadjuvant Capecitabine Improves Complete Response in Early Stage Breast Cancer

Novel BRAF Inhibitor Yields Dramatic Responses in Metastatic Melanoma





Day 3:

Novel Agent Motesanib (AMG-706) Active in Recurrent or Metastatic Breast Cancer

Interview with Dr Peter Kaufman on Motesanib for Breast Cancer (Podcast)

Weight-adjusted Dosing of Dalteparin Prevents VTE in Advanced Pancreatic Cancer

Pain Increases Risk for Malnutrition and Poor Performance Status in Cancer Patients

BRAF Mutation Analysis has Clinical Value in Stage III Colon Carcinoma

How Do Patients Perceive Oral Oncology Drugs?

Meta-analysis of Cetuximab plus Chemotherapy Confirms Benefit in NSCLC





Day 2:

Aspirin Associated with Lower Incidence of Colon Cancer in Patients with Lynch Syndrome

Does Endocrine Therapy Increase the Risk of Cardiac Events in Men with Prostate Cancer?

Panitumumab Added to FOLFIRI Boosts Survival in Patients with Metastatic Colorectal Cancer and Wild-Type KRAS Mutations

New Multi-kinase Inhibitor, Regorafenib, Shows Strong First-Line Activity in Metastatic Renal Cell Carcinoma

Amgen Reports Solid Trial Results for Denosumab in Breast and Other Solid Tumors





Day 1:

ECCO-ESMO Welcomes Oncology Professionals with Inspiration and Music

Resection in Women with Stage IV Breast Cancer Improves Survival

PI3K Activation Might Predict Trastuzumab Resistance

Two New Blood Tests Improve Early Detection of GI and Colorectal Cancers

Mutations in EGFR Gene Confer Beneficial Response to Oral TKI Gefitinib in NSCLC

Dutasteride Reduces Prostate Cancer Risk in High-Risk Men

 
Advertisement

   
   
 
   

Intellisphere, LLC l 666 Plainsboro Road, Building 300, Plainsboro, NJ 08536 l P 609-716-7777 l F 609-716-4747

Copyright ©MDNG 2006-2010
Intellisphere, LLC
All Rights Reserved